| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | UBA5 KIF21B ABCC4 ABCA1 MYH13 ATRX DNAH10 MYO10 KIF21A PSMC5 DICER1 DDX50 ATP11A TOP2B | 1.08e-05 | 614 | 114 | 14 | GO:0140657 |
| GeneOntologyBiologicalProcess | synaptic signaling | GAD2 RAPSN FXR2 DTNA SYNE1 LRRK2 PSMC5 GRIN2B FABP5 ITPR1 SLC8A3 LYPD1 SERPINE2 FXR1 IGF1R GUCY1A1 PTPRN2 PLCL1 CDH1 CNR1 | 3.16e-07 | 976 | 113 | 20 | GO:0099536 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | GAD2 RAPSN FXR2 DTNA SYNE1 LRRK2 PSMC5 GRIN2B FABP5 SLC8A3 LYPD1 SERPINE2 FXR1 IGF1R GUCY1A1 PTPRN2 PLCL1 CDH1 CNR1 | 7.86e-07 | 939 | 113 | 19 | GO:0099537 |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | GAD2 RAPSN FXR2 DTNA SYNE1 LRRK2 PSMC5 GRIN2B SLC8A3 LYPD1 SERPINE2 FXR1 IGF1R GUCY1A1 PTPRN2 PLCL1 CDH1 CNR1 | 3.02e-06 | 931 | 113 | 18 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | GAD2 RAPSN FXR2 DTNA SYNE1 LRRK2 PSMC5 GRIN2B SLC8A3 LYPD1 SERPINE2 FXR1 IGF1R GUCY1A1 PTPRN2 PLCL1 CDH1 CNR1 | 3.02e-06 | 931 | 113 | 18 | GO:0007268 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | RAPSN FXR2 SYNE1 LRRK2 PSMC5 GRIN2B FABP5 SLC8A3 SERPINE2 FXR1 IGF1R GUCY1A1 PLCL1 CDH1 CNR1 | 3.45e-06 | 664 | 113 | 15 | GO:0099177 |
| GeneOntologyBiologicalProcess | forebrain development | KIF21B ATRX FXR2 USP9X LRRK2 DICER1 FXR1 IGF1R UCHL5 CDH1 TOP2B PHLPP2 | 1.56e-05 | 489 | 113 | 12 | GO:0030900 |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | RAPSN FXR2 SYNE1 LRRK2 PSMC5 GRIN2B SLC8A3 SERPINE2 FXR1 IGF1R GUCY1A1 PLCL1 CDH1 CNR1 | 1.60e-05 | 663 | 113 | 14 | GO:0050804 |
| GeneOntologyBiologicalProcess | brain development | KIF21B ATRX FXR2 USP9X LRRK2 GRIN2B DICER1 SERPINE2 TTBK1 FXR1 IGF1R UCHL5 CDH1 NIPBL TOP2B PHLPP2 | 1.80e-05 | 859 | 113 | 16 | GO:0007420 |
| GeneOntologyBiologicalProcess | head development | KIF21B ATRX FXR2 USP9X LRRK2 GRIN2B DICER1 SERPINE2 TTBK1 FXR1 IGF1R UCHL5 CDH1 NIPBL TOP2B PHLPP2 | 4.07e-05 | 919 | 113 | 16 | GO:0060322 |
| GeneOntologyBiologicalProcess | negative regulation of protein maturation | 4.39e-05 | 36 | 113 | 4 | GO:1903318 | |
| GeneOntologyBiologicalProcess | negative regulation of protein processing | 4.39e-05 | 36 | 113 | 4 | GO:0010955 | |
| GeneOntologyBiologicalProcess | regulation of nervous system process | 5.09e-05 | 175 | 113 | 7 | GO:0031644 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | DYNLT2B IFT140 MYO10 SYNE1 SDCCAG8 LRRK2 GRIN2B SKIL ITPR1 SERPINE2 IGF1R RP1 CDH1 PREX1 CNR1 | 5.90e-05 | 846 | 113 | 15 | GO:0120035 |
| GeneOntologyBiologicalProcess | retrograde trans-synaptic signaling | 6.94e-05 | 15 | 113 | 3 | GO:0098917 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | DYNLT2B IFT140 MYO10 SYNE1 SDCCAG8 LRRK2 GRIN2B SKIL ITPR1 SERPINE2 IGF1R RP1 CDH1 PREX1 CNR1 | 7.38e-05 | 863 | 113 | 15 | GO:0031344 |
| GeneOntologyBiologicalProcess | central nervous system development | KIF21B ATRX FXR2 USP9X LRRK2 GRIN2B DICER1 SLC8A3 SERPINE2 TTBK1 FXR1 IGF1R TENM4 UCHL5 CDH1 NIPBL TOP2B PHLPP2 | 8.69e-05 | 1197 | 113 | 18 | GO:0007417 |
| GeneOntologyBiologicalProcess | regulation of translation at presynapse, modulating synaptic transmission | 8.89e-05 | 3 | 113 | 2 | GO:0099577 | |
| GeneOntologyBiologicalProcess | regulation of translation at presynapse | 8.89e-05 | 3 | 113 | 2 | GO:0140244 | |
| GeneOntologyBiologicalProcess | telencephalon development | 8.96e-05 | 332 | 113 | 9 | GO:0021537 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, glutamatergic | 1.52e-04 | 92 | 113 | 5 | GO:0051966 | |
| GeneOntologyBiologicalProcess | positive regulation of glial cell differentiation | 3.08e-04 | 59 | 113 | 4 | GO:0045687 | |
| GeneOntologyBiologicalProcess | hippocampus development | 3.21e-04 | 108 | 113 | 5 | GO:0021766 | |
| GeneOntologyBiologicalProcess | regulation of cilium assembly | 3.21e-04 | 108 | 113 | 5 | GO:1902017 | |
| GeneOntologyBiologicalProcess | negative regulation of cGMP-mediated signaling | 4.40e-04 | 6 | 113 | 2 | GO:0010754 | |
| GeneOntologyBiologicalProcess | retrograde trans-synaptic signaling by lipid | 4.40e-04 | 6 | 113 | 2 | GO:0098920 | |
| GeneOntologyBiologicalProcess | retrograde trans-synaptic signaling by endocannabinoid | 4.40e-04 | 6 | 113 | 2 | GO:0098921 | |
| GeneOntologyBiologicalProcess | modulation of excitatory postsynaptic potential | 4.47e-04 | 65 | 113 | 4 | GO:0098815 | |
| GeneOntologyCellularComponent | somatodendritic compartment | KIF21B GAD2 FXR2 MYO10 SYNE1 KIF21A LRRK2 MAGOHB GRIN2B KCNIP1 DICER1 ITPR1 SLC8A3 SERPINE2 TTBK1 FXR1 IGF1R AIF1 WDFY3 PREX1 PDE11A | 3.59e-06 | 1228 | 116 | 21 | GO:0036477 |
| GeneOntologyCellularComponent | axon | KIF21B GAD2 DTNA USP9X KIF21A LRRK2 GRIN2B DICER1 SLC8A3 FXR1 IGF1R PTPRN2 WDFY3 CDH1 PREX1 CNR1 | 3.32e-05 | 891 | 116 | 16 | GO:0030424 |
| GeneOntologyCellularComponent | postsynapse | RPL21 KIF21B RAPSN ATR FXR2 USP9X SYNE1 LRRK2 PSMC5 GRIN2B DICER1 FABP5 ITPR1 SLC8A3 FXR1 IGF1R CDH1 | 4.60e-05 | 1018 | 116 | 17 | GO:0098794 |
| GeneOntologyCellularComponent | distal axon | KIF21B USP9X LRRK2 GRIN2B DICER1 SLC8A3 PTPRN2 CDH1 PREX1 CNR1 | 1.57e-04 | 435 | 116 | 10 | GO:0150034 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | GAD2 ABCA1 RASA2 SYNE1 UNC45A DICER1 ITPR1 CCNF FAT1 SLC8A3 TTBK1 FXR1 AIF1 CDH1 PREX1 | 2.05e-04 | 934 | 116 | 15 | GO:0048471 |
| GeneOntologyCellularComponent | neuronal cell body | GAD2 MYO10 LRRK2 MAGOHB GRIN2B KCNIP1 ITPR1 SLC8A3 SERPINE2 TTBK1 IGF1R AIF1 WDFY3 PDE11A | 2.19e-04 | 835 | 116 | 14 | GO:0043025 |
| GeneOntologyCellularComponent | microtubule associated complex | 2.81e-04 | 161 | 116 | 6 | GO:0005875 | |
| GeneOntologyCellularComponent | myosin filament | 3.50e-04 | 25 | 116 | 3 | GO:0032982 | |
| GeneOntologyCellularComponent | platelet dense granule membrane | 4.51e-04 | 6 | 116 | 2 | GO:0031088 | |
| GeneOntologyCellularComponent | glutamatergic synapse | KIF21B FXR2 LRRK2 STK38 GRIN2B DICER1 FABP5 FXR1 IGF1R TENM4 GUCY1A1 CDH1 CNR1 | 6.08e-04 | 817 | 116 | 13 | GO:0098978 |
| GeneOntologyCellularComponent | cytosolic proteasome complex | 6.30e-04 | 7 | 116 | 2 | GO:0031597 | |
| GeneOntologyCellularComponent | cell body | GAD2 MYO10 LRRK2 MAGOHB GRIN2B KCNIP1 ITPR1 SLC8A3 SERPINE2 TTBK1 IGF1R AIF1 WDFY3 PDE11A | 6.36e-04 | 929 | 116 | 14 | GO:0044297 |
| GeneOntologyCellularComponent | myofibril | 8.34e-04 | 273 | 116 | 7 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.18e-03 | 290 | 116 | 7 | GO:0043292 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 1.26e-03 | 293 | 116 | 7 | GO:0030658 | |
| Domain | FXR_C1 | 3.69e-05 | 2 | 114 | 2 | IPR032172 | |
| Domain | FXR_C1 | 3.69e-05 | 2 | 114 | 2 | PF16096 | |
| Domain | Agenet | 1.10e-04 | 3 | 114 | 2 | PF05641 | |
| Domain | AGENET_LIKE | 1.10e-04 | 3 | 114 | 2 | PS51641 | |
| Domain | FXMRP1_C_core | 1.10e-04 | 3 | 114 | 2 | IPR022034 | |
| Domain | Agenet-like_dom | 1.10e-04 | 3 | 114 | 2 | IPR008395 | |
| Domain | FXMRP1_C_core | 1.10e-04 | 3 | 114 | 2 | PF12235 | |
| Domain | P-loop_NTPase | KIF21B ABCC4 ABCA1 MYH13 ATRX DNAH10 MYO10 KIF21A LRRK2 BMS1 PSMC5 DICER1 EFTUD2 NWD2 DDX50 | 1.99e-04 | 848 | 114 | 15 | IPR027417 |
| Domain | ARM-type_fold | 2.34e-04 | 339 | 114 | 9 | IPR016024 | |
| Domain | WD40 | 2.40e-04 | 268 | 114 | 8 | SM00320 | |
| Domain | WD40_repeat | 2.65e-04 | 272 | 114 | 8 | IPR001680 | |
| Domain | GST_alpha | 3.65e-04 | 5 | 114 | 2 | IPR003080 | |
| Domain | WD40_repeat_dom | 4.77e-04 | 297 | 114 | 8 | IPR017986 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RPL21 SLC25A24 REXO4 HK2 ATR ATRX DNAH10 POLA1 USP9X SYNE1 POLR2A BMS1 PEPD PSMC5 UNC45A SSRP1 PRPF40A DICER1 EFTUD2 WDR3 FXR1 DDX50 UCHL5 NIPBL TOP2B | 7.49e-12 | 1425 | 116 | 25 | 30948266 |
| Pubmed | RPL21 UBA5 POLA1 USP9X POLR2A NELFB PSMC5 UNC45A SSRP1 EFTUD2 WDR3 FXR1 COQ8A TUBGCP3 TOP2B | 3.80e-09 | 638 | 116 | 15 | 33239621 | |
| Pubmed | REXO4 FXR2 SYNE1 POLR2A BMS1 SSRP1 PRPF40A WDR3 FXR1 UTP11 TOP2B | 1.64e-08 | 332 | 116 | 11 | 25693804 | |
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | REXO4 POLR2A BMS1 SSRP1 EFTUD2 WDR3 DDX50 UTP11 MRPL24 NIPBL | 1.80e-08 | 259 | 116 | 10 | 30404004 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RPL21 REXO4 HK2 RASA2 POLA1 KIF21A POLR2A BMS1 PSMC5 UNC45A SSRP1 FABP5 EFTUD2 WDR3 FXR1 DDX50 TUBGCP3 WDFY3 NIPBL TOP2B | 2.20e-08 | 1353 | 116 | 20 | 29467282 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | ATRX FXR2 USP9X POLR2A SSRP1 DICER1 ITPR1 WDR3 FXR1 DDX50 CDH1 TOP2B | 3.04e-08 | 440 | 116 | 12 | 34244565 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | RPL21 ATRX USP9X POLR2A ITPR1 THBS1 SERPINE2 NWD2 FXR1 TENM4 TUBGCP3 TOP2B | 7.00e-08 | 475 | 116 | 12 | 31040226 |
| Pubmed | RPL21 KIF21B REXO4 FXR2 MYO10 POLR2A BMS1 SSRP1 PRPF40A DICER1 WDR3 FXR1 DDX50 UCHL5 | 1.43e-07 | 723 | 116 | 14 | 34133714 | |
| Pubmed | RPL21 ATR ATRX BMS1 SSRP1 EFTUD2 WDR3 DDX50 UTP11 NIPBL TOP2B | 1.72e-07 | 419 | 116 | 11 | 15635413 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | FXR2 KIF21A BMS1 MAGOHB SSRP1 PRPF40A EFTUD2 FXR1 DDX50 TOP2B | 1.73e-07 | 330 | 116 | 10 | 33301849 |
| Pubmed | RPL21 ATRX POLR2A MAGOHB PSMC5 PRPF40A FABP5 ITPR1 EFTUD2 DDX50 DCLRE1A NIPBL TOP2B | 2.95e-07 | 652 | 116 | 13 | 31180492 | |
| Pubmed | RPL21 REXO4 FXR2 POLA1 USP9X POLR2A BMS1 PSMC5 PRPF40A DICER1 WDR3 FXR1 NIPBL | 3.00e-07 | 653 | 116 | 13 | 22586326 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SLC25A24 REXO4 SYNE1 POLR2A BMS1 STK38 SSRP1 PRPF40A EFTUD2 NWD2 DDX50 SCG3 TUBGCP3 SRPX NIPBL TOP2B | 6.51e-07 | 1082 | 116 | 16 | 38697112 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | RPL21 REXO4 FXR2 BMS1 C19orf47 SSRP1 PRPF40A FABP5 EFTUD2 WDR3 DDX50 TOP2B | 9.16e-07 | 605 | 116 | 12 | 28977666 |
| Pubmed | RPL21 REXO4 FXR2 BMS1 UNC45A SSRP1 PRPF40A EFTUD2 WDR3 FXR1 DDX50 TUBGCP3 MRPL24 TOP2B | 9.46e-07 | 847 | 116 | 14 | 35850772 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | RPL21 SLC25A24 REXO4 FXR2 BMS1 MAGOHB UNC45A SSRP1 EFTUD2 WDR3 THBS1 FXR1 DDX50 UTP11 GAN CDH1 MRPL24 | 9.63e-07 | 1257 | 116 | 17 | 36526897 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | RPL21 DOCK4 ATRX FXR2 USP9X POLR2A NELFB PSMC5 UNC45A PRPF40A FABP5 EFTUD2 FBLN1 TTBK1 IGF1R PIP5K1B PREX1 | 1.29e-06 | 1284 | 116 | 17 | 17353931 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | FXR2 MYO10 DTNA POLA1 BMS1 PSMC5 UNC45A DICER1 EFTUD2 WDR3 UCHL5 TUBGCP3 SRPX TARBP1 PHLPP2 | 1.34e-06 | 1005 | 116 | 15 | 19615732 |
| Pubmed | DOCK4 HK2 FXR2 USP9X POLR2A PIK3R3 SSRP1 FABP5 FXR1 DDX50 CDH1 TOP2B | 1.49e-06 | 634 | 116 | 12 | 34591612 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RPL21 USP9X SYNE1 POLR2A C19orf47 PSMC5 SSRP1 PRPF40A DICER1 EFTUD2 WDR3 FXR1 DDX50 NIPBL TOP2B | 1.69e-06 | 1024 | 116 | 15 | 24711643 |
| Pubmed | 2.39e-06 | 441 | 116 | 10 | 31239290 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | RPL21 REXO4 FXR2 SYNE1 POLR2A BMS1 MAGOHB SSRP1 PRPF40A EFTUD2 FXR1 DDX50 UTP11 | 3.14e-06 | 807 | 116 | 13 | 22681889 |
| Pubmed | 3.45e-06 | 31 | 116 | 4 | 26222436 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | UBA5 ATR ATRX KIF21A PSMC5 UNC45A PRPF40A EFTUD2 UCHL5 TUBGCP3 NIPBL | 4.23e-06 | 582 | 116 | 11 | 20467437 |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | RPL21 FXR2 SYNE1 POLR2A STK38 MAGOHB SSRP1 PRPF40A EFTUD2 FXR1 DDX50 TOP2B | 5.02e-06 | 714 | 116 | 12 | 28302793 |
| Pubmed | GAD2 LURAP1 ATRX USP9X SYNE1 KIF21A GRIN2B SKIL WDR3 THBS1 SERPINE2 SCG3 WDFY3 PREX1 NIPBL TARBP1 | 5.92e-06 | 1285 | 116 | 16 | 35914814 | |
| Pubmed | RPL21 MYH13 ATRX DTNA SYNE1 KIF21A SSRP1 FXR1 DDX50 SCG3 ATP11A MYOM2 CDH1 PREX1 NIPBL TOP2B MYBPC2 | 6.06e-06 | 1442 | 116 | 17 | 35575683 | |
| Pubmed | 6.65e-06 | 208 | 116 | 7 | 11790298 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 6.85e-06 | 497 | 116 | 10 | 36774506 | |
| Pubmed | RPL21 FXR2 USP9X POLR2A BMS1 NELFB SSRP1 EFTUD2 FXR1 DDX50 TOP2B | 7.11e-06 | 615 | 116 | 11 | 31048545 | |
| Pubmed | 7.92e-06 | 300 | 116 | 8 | 28561026 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DYNLT2B ABCC4 ATRX RASA2 DTNA RNF144A SDCCAG8 PIK3R3 TOM1L1 PEPD IGF1R COQ8A GUCY1A1 PTPRN2 SLC9A7 ATP11A PNPLA7 | 9.21e-06 | 1489 | 116 | 17 | 28611215 |
| Pubmed | WDR64 RASA2 FXR2 USP9X THBS1 COQ8A PTPRN2 WDFY3 PREX1 NIPBL TARBP1 | 1.00e-05 | 638 | 116 | 11 | 31182584 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 10225949 | ||
| Pubmed | Cadherin-dependent filopodia control preimplantation embryo compaction. | 1.10e-05 | 2 | 116 | 2 | 24270889 | |
| Pubmed | An integrated workflow for 2D and 3D posture analysis during vestibular system testing in mice. | 1.10e-05 | 2 | 116 | 2 | 38107632 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 21072162 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 36045406 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 32849999 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 19157508 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 10196376 | ||
| Pubmed | A key role for E-cadherin in intestinal homeostasis and Paneth cell maturation. | 1.10e-05 | 2 | 116 | 2 | 21179475 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 34566562 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 12381297 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 26005403 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 32214335 | ||
| Pubmed | Comparative genomic sequence analysis of the FXR gene family: FMR1, FXR1, and FXR2. | 1.10e-05 | 2 | 116 | 2 | 11735223 | |
| Pubmed | Spontaneous and Acetylcholine Evoked Calcium Transients in the Developing Mouse Utricle. | 1.10e-05 | 2 | 116 | 2 | 31133810 | |
| Pubmed | Transfer of hepatocellular microRNA regulates cytochrome P450 2E1 in renal tubular cells. | 1.10e-05 | 2 | 116 | 2 | 33232872 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 32771977 | ||
| Pubmed | D-ꞵ-hydroxybutyrate stabilizes hippocampal CA3-CA1 circuit during acute insulin resistance. | 1.10e-05 | 2 | 116 | 2 | 38818236 | |
| Pubmed | Phosphorylation of P-Rex1 at serine 1169 participates in IGF-1R signaling in breast cancer cells. | 1.10e-05 | 2 | 116 | 2 | 23899556 | |
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | 1.29e-05 | 321 | 116 | 8 | 32098917 | |
| Pubmed | 1.43e-05 | 234 | 116 | 7 | 36243803 | ||
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 1.47e-05 | 430 | 116 | 9 | 38172120 | |
| Pubmed | 1.48e-05 | 327 | 116 | 8 | 31409639 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.65e-05 | 332 | 116 | 8 | 32786267 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | RPL21 FXR2 MYO10 SYNE1 UNC45A SSRP1 PRPF40A ITPR1 EFTUD2 WDR3 FXR1 DDX50 UTP11 | 1.77e-05 | 949 | 116 | 13 | 36574265 |
| Pubmed | 1.81e-05 | 162 | 116 | 6 | 23012479 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | RPL21 HK2 FXR2 POLA1 USP9X KIF21A POLR2A NELFB MAGOHB UNC45A SSRP1 EFTUD2 FXR1 NIPBL TARBP1 TOP2B | 1.95e-05 | 1415 | 116 | 16 | 28515276 |
| Pubmed | The eutheria-specific miR-290 cluster modulates placental growth and maternal-fetal transport. | 1.96e-05 | 16 | 116 | 3 | 28935707 | |
| Pubmed | Mapping Extracellular Protein-Protein Interactions Using Extracellular Proximity Labeling (ePL). | 2.02e-05 | 247 | 116 | 7 | 39238192 | |
| Pubmed | IFT140 FXR2 POLR2A PIK3R3 SSRP1 SKIL PRPF40A DICER1 FAT1 FXR1 COQ8A TUBGCP3 WDFY3 TCF7L1 | 2.19e-05 | 1116 | 116 | 14 | 31753913 | |
| Pubmed | 2.24e-05 | 251 | 116 | 7 | 28077445 | ||
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 2.46e-05 | 171 | 116 | 6 | 20201926 | |
| Pubmed | 2.63e-05 | 463 | 116 | 9 | 34901782 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RPL21 ATR ATRX POLR2A MAGOHB SSRP1 SKIL PRPF40A EFTUD2 WDR3 DDX50 UCHL5 DCLRE1A NIPBL TOP2B | 2.73e-05 | 1294 | 116 | 15 | 30804502 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | RPL21 UBA5 HK2 POLA1 USP9X KIF21A POLR2A TOM1L1 PEPD NELFB PSMC5 UNC45A SSRP1 EFTUD2 SERPINE2 UCHL5 | 2.73e-05 | 1455 | 116 | 16 | 22863883 |
| Pubmed | RPL21 FXR2 USP9X BMS1 MAGOHB PRPF40A EFTUD2 FXR1 DDX50 MRPL24 TOP2B | 2.79e-05 | 713 | 116 | 11 | 29802200 | |
| Pubmed | Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer. | 2.81e-05 | 52 | 116 | 4 | 24591637 | |
| Pubmed | 2.84e-05 | 18 | 116 | 3 | 33323119 | ||
| Pubmed | Spatial control of nucleoporin condensation by fragile X-related proteins. | 3.30e-05 | 3 | 116 | 2 | 32706158 | |
| Pubmed | The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2. | 3.30e-05 | 3 | 116 | 2 | 7489725 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 8668200 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 9524259 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 27770568 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 36566254 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 19487368 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 33477899 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 20442204 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 27472395 | ||
| Pubmed | LLPS of FXR proteins drives replication organelle clustering for β-coronaviral proliferation. | 3.30e-05 | 3 | 116 | 2 | 38587486 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 17360756 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 31738404 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 17360667 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 27979966 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 29847800 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 26148972 | ||
| Pubmed | Differential expression of FMR1, FXR1 and FXR2 proteins in human brain and testis. | 3.30e-05 | 3 | 116 | 2 | 9259278 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 29681797 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 37672887 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 28121627 | ||
| Pubmed | Fragile X-related proteins regulate mammalian circadian behavioral rhythms. | 3.30e-05 | 3 | 116 | 2 | 18589395 | |
| Pubmed | Characterization of the TRBP domain required for dicer interaction and function in RNA interference. | 3.30e-05 | 3 | 116 | 2 | 19422693 | |
| Pubmed | ABC transporters as differentiation markers in glioblastoma cells. | 3.30e-05 | 3 | 116 | 2 | 25028266 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 12417522 | ||
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 14742711 | ||
| Pubmed | Human nuclear Dicer restricts the deleterious accumulation of endogenous double-stranded RNA. | 3.30e-05 | 3 | 116 | 2 | 24814348 | |
| Pubmed | MACF1 links Rapsyn to microtubule- and actin-binding proteins to maintain neuromuscular synapses. | 3.30e-05 | 3 | 116 | 2 | 30842214 | |
| Pubmed | 3.30e-05 | 3 | 116 | 2 | 20655775 | ||
| Interaction | SNIP1 interactions | REXO4 ATR POLR2A BMS1 SSRP1 PRPF40A EFTUD2 WDR3 DDX50 UTP11 AIF1 MRPL24 NIPBL | 6.91e-07 | 417 | 114 | 13 | int:SNIP1 |
| Interaction | SEC24C interactions | 2.73e-06 | 207 | 114 | 9 | int:SEC24C | |
| Interaction | H3C1 interactions | REXO4 ATRX POLA1 SYNE1 POLR2A LRRK2 NELFB MAGOHB SSRP1 SUV39H2 EFTUD2 FBLN1 THBS1 XIRP2 CDH1 NIPBL TARBP1 TOP2B | 3.00e-06 | 901 | 114 | 18 | int:H3C1 |
| Interaction | SNW1 interactions | UBA5 ATR ATRX KIF21A MAGOHB PSMC5 UNC45A SSRP1 SKIL PRPF40A EFTUD2 CCNF FXR1 UCHL5 TUBGCP3 NIPBL | 4.72e-06 | 747 | 114 | 16 | int:SNW1 |
| Interaction | BRCA1 interactions | RPL21 CFAP47 DOCK4 DYNLT2B HK2 ATR FXR2 DTNA USP9X POLR2A NELFB PSMC5 SSRP1 ITPR1 EFTUD2 CABYR UCHL5 DCLRE1A CDH1 NIPBL TOP2B | 6.18e-06 | 1249 | 114 | 21 | int:BRCA1 |
| Interaction | CCDC92 interactions | 1.23e-05 | 53 | 114 | 5 | int:CCDC92 | |
| Interaction | SIRT6 interactions | ATRX FXR2 USP9X POLR2A SSRP1 DICER1 ITPR1 EFTUD2 WDR3 FAT1 FXR1 DDX50 CDH1 TOP2B | 1.25e-05 | 628 | 114 | 14 | int:SIRT6 |
| Interaction | CBS interactions | 1.29e-05 | 137 | 114 | 7 | int:CBS | |
| Interaction | STIP1 interactions | RPL21 UBA5 POLA1 USP9X POLR2A LRRK2 NELFB PSMC5 UNC45A SSRP1 FABP5 EFTUD2 CCNF WDR3 FXR1 COQ8A TUBGCP3 TOP2B | 1.36e-05 | 1006 | 114 | 18 | int:STIP1 |
| Interaction | MST1R interactions | 1.83e-05 | 200 | 114 | 8 | int:MST1R | |
| Interaction | UBR4 interactions | RAPSN MYO10 USP9X KIF21A STK38 PSMC5 PRPF40A EFTUD2 CCNF TUBGCP3 | 2.03e-05 | 334 | 114 | 10 | int:UBR4 |
| Interaction | TERF2 interactions | FXR2 MYO10 USP9X SYNE1 PIK3R3 MAGOHB SSRP1 PRPF40A MYOM2 ARMH3 | 2.36e-05 | 340 | 114 | 10 | int:TERF2 |
| Interaction | EIF4A3 interactions | RPL21 DOCK4 BMS1 C19orf47 STK38 MAGOHB UNC45A SSRP1 PRPF40A EFTUD2 CCNF IGF1R | 2.61e-05 | 499 | 114 | 12 | int:EIF4A3 |
| Interaction | KIF21A interactions | 2.93e-05 | 105 | 114 | 6 | int:KIF21A | |
| Interaction | PPME1 interactions | 2.99e-05 | 156 | 114 | 7 | int:PPME1 | |
| Interaction | ENO1 interactions | WDR64 HK2 ATR POLA1 LRRK2 UNC45A SSRP1 FABP5 EFTUD2 CCNF CABYR FXR1 SCG3 CDH1 | 4.20e-05 | 701 | 114 | 14 | int:ENO1 |
| Interaction | NPM1 interactions | RPL21 DOCK4 REXO4 ATR FXR2 BMS1 STK38 PSMC5 SSRP1 DICER1 EFTUD2 CCNF WDR3 FXR1 DDX50 GAN RP1 MRPL24 TOP2B | 4.21e-05 | 1201 | 114 | 19 | int:NPM1 |
| Interaction | IFI16 interactions | REXO4 FXR2 SYNE1 POLR2A BMS1 STK38 SSRP1 PRPF40A EFTUD2 WDR3 FXR1 DDX50 UTP11 TOP2B | 5.12e-05 | 714 | 114 | 14 | int:IFI16 |
| Interaction | FBXO22 interactions | KIF21B MYH13 USP9X POLR2A EFTUD2 CCNF IGF1R XIRP2 GAN MYOM2 RP1 ARMH3 | 5.60e-05 | 540 | 114 | 12 | int:FBXO22 |
| Interaction | POLR2E interactions | 6.44e-05 | 308 | 114 | 9 | int:POLR2E | |
| Interaction | AAMP interactions | 6.68e-05 | 75 | 114 | 5 | int:AAMP | |
| Interaction | PSMB5 interactions | 7.09e-05 | 242 | 114 | 8 | int:PSMB5 | |
| Interaction | SIRT7 interactions | RPL21 REXO4 ATR FXR2 POLA1 USP9X POLR2A BMS1 PSMC5 PRPF40A DICER1 WDR3 FXR1 NIPBL | 7.95e-05 | 744 | 114 | 14 | int:SIRT7 |
| Interaction | NOP56 interactions | RPL21 REXO4 ATRX BMS1 SSRP1 EFTUD2 CCNF WDR3 FXR1 DDX50 CDH1 TOP2B | 9.36e-05 | 570 | 114 | 12 | int:NOP56 |
| Interaction | CDC5L interactions | UBA5 ATR SYNE1 KIF21A POLR2A BMS1 PSMC5 UNC45A PRPF40A EFTUD2 CCNF FXR1 UCHL5 TUBGCP3 NIPBL | 9.52e-05 | 855 | 114 | 15 | int:CDC5L |
| Interaction | MAU2 interactions | 1.24e-04 | 136 | 114 | 6 | int:MAU2 | |
| Interaction | MAGOH interactions | 1.30e-04 | 264 | 114 | 8 | int:MAGOH | |
| Interaction | SUMO2 interactions | HK2 ATRX POLA1 USP9X POLR2A LRRK2 PSMC5 SSRP1 FABP5 EFTUD2 NIPBL TOP2B | 1.31e-04 | 591 | 114 | 12 | int:SUMO2 |
| Interaction | HECTD1 interactions | RPL21 REXO4 FXR2 USP9X BMS1 C19orf47 SSRP1 PRPF40A EFTUD2 CCNF WDR3 FXR1 DDX50 TUBGCP3 CDH1 TOP2B | 1.33e-04 | 984 | 114 | 16 | int:HECTD1 |
| Interaction | WASF2 interactions | 1.83e-04 | 146 | 114 | 6 | int:WASF2 | |
| Interaction | DOT1L interactions | RPL21 REXO4 ATRX FXR2 BMS1 UNC45A SSRP1 PRPF40A EFTUD2 WDR3 FXR1 DDX50 TUBGCP3 TOP2B | 1.86e-04 | 807 | 114 | 14 | int:DOT1L |
| Interaction | PHC1P1 interactions | 1.89e-04 | 4 | 114 | 2 | int:PHC1P1 | |
| Interaction | RDX interactions | 2.14e-04 | 284 | 114 | 8 | int:RDX | |
| Interaction | PA2G4 interactions | 2.14e-04 | 284 | 114 | 8 | int:PA2G4 | |
| Interaction | MSANTD3 interactions | 2.18e-04 | 21 | 114 | 3 | int:MSANTD3 | |
| Interaction | CSNK2B interactions | DYNLT2B ATRX FXR2 POLR2A BMS1 GRIN2B SSRP1 EFTUD2 CCNF FXR1 UCHL5 TOP2B | 2.20e-04 | 625 | 114 | 12 | int:CSNK2B |
| Interaction | MEN1 interactions | RPL21 REXO4 ATRX FXR2 POLA1 POLR2A BMS1 UNC45A SSRP1 PRPF40A EFTUD2 WDR3 FXR1 DDX50 MRPL24 TOP2B | 2.20e-04 | 1029 | 114 | 16 | int:MEN1 |
| Interaction | AIRE interactions | 2.26e-04 | 97 | 114 | 5 | int:AIRE | |
| Interaction | MRE11 interactions | 2.29e-04 | 287 | 114 | 8 | int:MRE11 | |
| Interaction | ARHGEF7 interactions | 2.36e-04 | 153 | 114 | 6 | int:ARHGEF7 | |
| Interaction | ZBTB2 interactions | FXR2 KIF21A BMS1 MAGOHB SSRP1 PRPF40A EFTUD2 FXR1 DDX50 TOP2B | 2.40e-04 | 450 | 114 | 10 | int:ZBTB2 |
| Interaction | CCT8 interactions | UBA5 SYNE1 KIF21A LRRK2 NELFB PSMC5 SUV39H2 EFTUD2 CCNF GAN CDH1 | 2.88e-04 | 550 | 114 | 11 | int:CCT8 |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 5.06e-04 | 8 | 78 | 2 | 658 | |
| GeneFamily | WD repeat domain containing | 9.39e-04 | 262 | 78 | 6 | 362 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 9.85e-04 | 11 | 78 | 2 | 1168 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK4 SLC25A24 ATR ATRX MYO10 USP9X DICER1 ITPR1 FAT1 FXR1 IGF1R TUBGCP3 WDFY3 NIPBL PHLPP2 | 5.81e-06 | 856 | 116 | 15 | M4500 |
| Coexpression | SIMBULAN_UV_RESPONSE_NORMAL_DN | 1.35e-05 | 33 | 116 | 4 | M16114 | |
| Coexpression | FOROUTAN_PRODRANK_TGFB_EMT_UP | 1.90e-05 | 185 | 116 | 7 | M42503 | |
| Coexpression | WANG_CISPLATIN_RESPONSE_AND_XPC_UP | 1.90e-05 | 185 | 116 | 7 | M19511 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | RPL21 DYNLT2B ATR ATRX DTNA POLA1 PRPF40A FXR1 UCHL5 NAA30 NIPBL | 2.14e-05 | 523 | 116 | 11 | M12707 |
| Coexpression | FOROUTAN_TGFB_EMT_UP | 2.41e-05 | 192 | 116 | 7 | M42501 | |
| Coexpression | FUJII_YBX1_TARGETS_DN | 2.58e-05 | 194 | 116 | 7 | M14340 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | RPL21 DYNLT2B ATR ATRX DTNA POLA1 PRPF40A FXR1 UCHL5 NAA30 NIPBL | 2.59e-05 | 534 | 116 | 11 | MM1054 |
| Coexpression | GSE22033_WT_VS_PPARG_KO_MEF_UP | 2.66e-05 | 195 | 116 | 7 | M7694 | |
| Coexpression | GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN | 2.84e-05 | 197 | 116 | 7 | M3472 | |
| Coexpression | GSE360_L_DONOVANI_VS_L_MAJOR_DC_UP | 3.13e-05 | 200 | 116 | 7 | M5192 | |
| Coexpression | GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_UP | 3.13e-05 | 200 | 116 | 7 | M4355 | |
| Coexpression | HALLMARK_UV_RESPONSE_DN | 4.47e-05 | 144 | 116 | 6 | M5942 | |
| Coexpression | LAKE_ADULT_KIDNEY_C20_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_CORTEX | 6.05e-05 | 152 | 116 | 6 | M39239 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | 7.29e-05 | 399 | 116 | 9 | M41172 | |
| Coexpression | BURTON_ADIPOGENESIS_3 | 8.79e-05 | 101 | 116 | 5 | M1577 | |
| Coexpression | GSE21033_3H_VS_24H_POLYIC_STIM_DC_UP | 9.84e-05 | 166 | 116 | 6 | M7722 | |
| Coexpression | BURTON_ADIPOGENESIS_3 | 1.01e-04 | 104 | 116 | 5 | MM1180 | |
| Coexpression | HEVNER_CORTEX_RADIAL_GLIA_PROGENITORS | 1.33e-04 | 432 | 116 | 9 | MM419 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | DOCK4 UBA5 ATR POLA1 SDCCAG8 MAGOHB SUV39H2 PRPF40A CCNF WDR3 FXR1 DDX50 CDCA7 UCHL5 SLC9A7 MRPL24 TARBP1 | 1.53e-04 | 1407 | 116 | 17 | M14427 |
| Coexpression | LAKE_ADULT_KIDNEY_C6_PROXIMAL_TUBULE_EPITHELIAL_CELLS_FIBRINOGEN_POS_S3 | 1.58e-04 | 181 | 116 | 6 | M39225 | |
| Coexpression | TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN | 1.60e-04 | 24 | 116 | 3 | MM708 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_UP | DYNLT2B ABCC4 FXR2 DIPK1A STK38 PRPF40A FXR1 DDX50 MRPL24 NIPBL TOP2B | 1.66e-04 | 658 | 116 | 11 | M40871 |
| Coexpression | JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN | 1.67e-04 | 62 | 116 | 4 | M1417 | |
| Coexpression | JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN | 1.77e-04 | 63 | 116 | 4 | MM1147 | |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 1.98e-04 | 120 | 116 | 5 | M42505 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HOPC | 2.30e-04 | 366 | 116 | 8 | M39052 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 2.34e-04 | 276 | 116 | 7 | M3063 | |
| Coexpression | GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 2.43e-04 | 196 | 116 | 6 | M5349 | |
| Coexpression | GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_DN | 2.43e-04 | 196 | 116 | 6 | M5504 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_VS_INH_PRETREAT_AND_ACT_WITH_TCELL_MEMBRANES_MAST_CELL_DN | 2.50e-04 | 197 | 116 | 6 | M7345 | |
| Coexpression | GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_DN | 2.50e-04 | 197 | 116 | 6 | M7683 | |
| Coexpression | DAIRKEE_CANCER_PRONE_RESPONSE_E2 | 2.55e-04 | 28 | 116 | 3 | M6041 | |
| Coexpression | GSE43863_DAY6_EFF_VS_DAY150_MEM_TFH_CD4_TCELL_DN | 2.57e-04 | 198 | 116 | 6 | M9747 | |
| Coexpression | GSE22886_TCELL_VS_BCELL_NAIVE_DN | 2.57e-04 | 198 | 116 | 6 | M4426 | |
| Coexpression | GSE40666_UNTREATED_VS_IFNA_STIM_CD8_TCELL_90MIN_DN | 2.64e-04 | 199 | 116 | 6 | M9227 | |
| Coexpression | GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_DN | 2.71e-04 | 200 | 116 | 6 | M4667 | |
| Coexpression | GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_DN | 2.71e-04 | 200 | 116 | 6 | M8033 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_DN | 2.71e-04 | 200 | 116 | 6 | M8027 | |
| Coexpression | GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP | 2.71e-04 | 200 | 116 | 6 | M302 | |
| Coexpression | GSE27786_BCELL_VS_NKCELL_UP | 2.71e-04 | 200 | 116 | 6 | M4805 | |
| Coexpression | GSE557_CIITA_KO_VS_I_AB_KO_DC_DN | 2.71e-04 | 200 | 116 | 6 | M6014 | |
| Coexpression | GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_DN | 2.71e-04 | 200 | 116 | 6 | M7441 | |
| Coexpression | GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_UP | 2.71e-04 | 200 | 116 | 6 | M5087 | |
| Coexpression | GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_12H_UP | 2.71e-04 | 200 | 116 | 6 | M6418 | |
| Coexpression | GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP | 2.71e-04 | 200 | 116 | 6 | M6477 | |
| Coexpression | GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_DN | 2.71e-04 | 200 | 116 | 6 | M5271 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_45MIN_UP | 2.71e-04 | 200 | 116 | 6 | M6629 | |
| Coexpression | GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_DN | 2.71e-04 | 200 | 116 | 6 | M6556 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | DOCK4 KIF21B GAD2 KIF21A DICER1 TENM4 GUCY1A1 SLC9A7 TARBP1 CNR1 PDE11A | 2.93e-04 | 703 | 116 | 11 | M39070 |
| Coexpression | SWEET_LUNG_CANCER_KRAS_UP | 3.08e-04 | 484 | 116 | 9 | M19097 | |
| Coexpression | SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_CORRELATED_WITH_AGE_1DY_POSITIVE | 3.14e-04 | 30 | 116 | 3 | M41011 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_GLIAL | 3.19e-04 | 133 | 116 | 5 | M39020 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2A | CFAP47 DTNA LRRK2 KCNIP1 FABP5 FAT1 LYPD1 SERPINE2 SCG3 PREX1 | 3.40e-04 | 600 | 116 | 10 | M39055 |
| Coexpression | SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN | 3.47e-04 | 31 | 116 | 3 | M3732 | |
| Coexpression | KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION | 3.84e-04 | 77 | 116 | 4 | M2540 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 1.91e-05 | 280 | 113 | 9 | PCBC_ratio_ECTO blastocyst_vs_ECTO amniotic fluid MSC_cfr-2X-p05 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 2.27e-07 | 163 | 115 | 7 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.97e-07 | 177 | 115 | 7 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.15e-07 | 184 | 115 | 7 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.34e-07 | 185 | 115 | 7 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.75e-07 | 187 | 115 | 7 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 5.75e-07 | 187 | 115 | 7 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 6.39e-07 | 190 | 115 | 7 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.62e-07 | 191 | 115 | 7 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.10e-07 | 193 | 115 | 7 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-07 | 195 | 115 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-07 | 195 | 115 | 7 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.88e-07 | 196 | 115 | 7 | 61bee32ca299219f31a30b57124e44e85b798e9f | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 8.15e-07 | 197 | 115 | 7 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.43e-07 | 198 | 115 | 7 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | Biopsy_Other_PF-Epithelial-AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 8.72e-07 | 199 | 115 | 7 | 9a65acfe9bf500db72142469cf17bf0973540001 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.72e-07 | 199 | 115 | 7 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.02e-07 | 200 | 115 | 7 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Interneuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 9.02e-07 | 200 | 115 | 7 | f5c63ef52bd7a898cf009b8bf9b2f7f4890d1c9b | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Pax6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.13e-06 | 130 | 115 | 6 | 60e28d452d0e2af768459ba8dbe998117c94a251 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.80e-06 | 152 | 115 | 6 | fed80b467ec9e30c7f98bed6cc4f8c583b715e9e | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.37e-06 | 157 | 115 | 6 | 516903469756c5fabfdf56d7bd59b3bdd7b44e39 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 3.37e-06 | 157 | 115 | 6 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-A_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.34e-06 | 164 | 115 | 6 | beaa13a75c3bb72446c85084d75e9fe3f15fd3d4 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-A_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.34e-06 | 164 | 115 | 6 | d005cfd821b87548b075120bffe65a0be9860463 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.70e-06 | 172 | 115 | 6 | d354424c1f861b6607dfd63b9724f4c237b30275 | |
| ToppCell | E18.5-samps-Epithelial-Alveolar_epithelial-AT2|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.89e-06 | 173 | 115 | 6 | f6e36ea98a9c669ff393d141455aaecef083f738 | |
| ToppCell | P28-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.30e-06 | 175 | 115 | 6 | 8a4ed775ff973123dbcfe9c809959d11a62450c9 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor | 6.50e-06 | 176 | 115 | 6 | 3fee8a367bb9755aca1b7fcc968b08e51b6e9436 | |
| ToppCell | PND01-03-samps-Epithelial-Alveolar_epithelial-AT2|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 6.50e-06 | 176 | 115 | 6 | ac76f2cd6c63f30b38b89b58bad2baa4dde8ce3a | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.72e-06 | 177 | 115 | 6 | 3a150dcaefa342d49968b42c7cdb1fbb633adcd0 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-06 | 177 | 115 | 6 | 9b4c1ca5c6fca9a7a936dad49a04155903ef9c32 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.72e-06 | 177 | 115 | 6 | c9e5820ff0bc7ad1adcfb2651713fdfc58bced56 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.16e-06 | 179 | 115 | 6 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 7.40e-06 | 180 | 115 | 6 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.63e-06 | 181 | 115 | 6 | 0513b9e6673ff7bf8e72ba123ca3794b65d10170 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.88e-06 | 182 | 115 | 6 | 17ed11a7ea366dd3106400511d5e628d3f1a9c3e | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.13e-06 | 183 | 115 | 6 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2-Endothelial_Tip.Dcn.Dapl1_(Dapl1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.24e-06 | 106 | 115 | 5 | 7079111add27d7b3411dfe739280d62dc256a174 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2-Endothelial_Tip.Dcn.Dapl1_(Dapl1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.24e-06 | 106 | 115 | 5 | a6334b67be05f78145b57271b7959471b80bd67f | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 8.38e-06 | 184 | 115 | 6 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.38e-06 | 184 | 115 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.38e-06 | 184 | 115 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.38e-06 | 184 | 115 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.38e-06 | 184 | 115 | 6 | d0c212a8fbaad24597a84018442b25c61c17ea58 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.65e-06 | 185 | 115 | 6 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.92e-06 | 186 | 115 | 6 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 9.19e-06 | 187 | 115 | 6 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 9.19e-06 | 187 | 115 | 6 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.19e-06 | 187 | 115 | 6 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.19e-06 | 187 | 115 | 6 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.48e-06 | 188 | 115 | 6 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.48e-06 | 188 | 115 | 6 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.48e-06 | 188 | 115 | 6 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.77e-06 | 189 | 115 | 6 | e4efbb0733b382f4c855f6653dcddf36e0f8df28 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.77e-06 | 189 | 115 | 6 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 191 | 115 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-05 | 191 | 115 | 6 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 191 | 115 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial_progenitor|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.07e-05 | 192 | 115 | 6 | fa2420d6117d4800f60ef6a24bcf8bf54593cd1f | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial_progenitor-epi-tip_late|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.07e-05 | 192 | 115 | 6 | 87b60014202633a4f6d19b09a5dd9276c2edecfb | |
| ToppCell | Monocytes-Tissue-resident_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 1.10e-05 | 193 | 115 | 6 | 198552810dcac8d0ca63a78badd6702b49ff6edf | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.10e-05 | 193 | 115 | 6 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.10e-05 | 193 | 115 | 6 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.13e-05 | 194 | 115 | 6 | 52aebb0b563e2c2058e7f0554ae870e47692b163 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.13e-05 | 194 | 115 | 6 | bd06e2b8d8c06cddf2e4f58849b86e09013acae1 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.13e-05 | 194 | 115 | 6 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | Control-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 1.13e-05 | 194 | 115 | 6 | a01de094f7bfd099bcbb2f94224690a2efb887b4 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.17e-05 | 195 | 115 | 6 | ec12cfb2fce44cc2de4e198ef5af075e626f0329 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 195 | 115 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-05 | 197 | 115 | 6 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-05 | 197 | 115 | 6 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.24e-05 | 197 | 115 | 6 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-05 | 197 | 115 | 6 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 1.24e-05 | 197 | 115 | 6 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-05 | 197 | 115 | 6 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.24e-05 | 197 | 115 | 6 | b8f62fcd6eb8f47b3cc41f616126f82c68a36e87 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.24e-05 | 197 | 115 | 6 | 1638959d7aecb9fc5285eb7e4a3103ca437989e2 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor|Control_saline / Treatment groups by lineage, cell group, cell type | 1.27e-05 | 198 | 115 | 6 | 030ef63e2fc5b3d601c1a48462d797aa19ee7ff5 | |
| ToppCell | B_cell_maturation-CD34+_pro-B|B_cell_maturation / Lineage and Cell class | 1.27e-05 | 198 | 115 | 6 | 5737606e5e3dc56f11fdf70166caf4ba4a81bc9d | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.27e-05 | 198 | 115 | 6 | 81c4c5377d0901ee9594424f08b0e4101686c850 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-05 | 198 | 115 | 6 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.27e-05 | 198 | 115 | 6 | c4e7512f0e1d115f2be8acae6048eda8b6b640b2 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.27e-05 | 198 | 115 | 6 | aa80315395cb5dffc25927c8a77cd2037aea8772 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.31e-05 | 199 | 115 | 6 | a38a981cffa61c8444a980916de7414e689a1b63 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.31e-05 | 199 | 115 | 6 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 1.35e-05 | 200 | 115 | 6 | fd6b4ff4330db11c03f1eb4e06b43a162326f744 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Macroglial-Astrocyte|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.35e-05 | 200 | 115 | 6 | 158ba898312c73bcb54c675a4860874a1dd58662 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 1.35e-05 | 200 | 115 | 6 | 8795920911ee75c09a97cc948c14ad7301b27796 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-05 | 200 | 115 | 6 | b535323e18d9fb0dde1e0026df142c831e48c29f | |
| ToppCell | 10x_3'_v2v3-Neoplastic|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.35e-05 | 200 | 115 | 6 | e9c7d7cb5fa63fc92aa91d02ae8bd05438d465bc | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Macroglial|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.35e-05 | 200 | 115 | 6 | 46f99bed98da09e6d3f45d4443cbaa6b6c1589bb | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Car10|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.98e-05 | 127 | 115 | 5 | f808c727c0817ed10e76eaffa9493a516e9a6b50 | |
| ToppCell | facs-Thymus-Epithelium-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 132 | 115 | 5 | 6f711fe84135406a8114a898a14c5ea0dfad74f2 | |
| ToppCell | COVID-19-Mast_cells-Dendritic_cells|COVID-19 / group, cell type (main and fine annotations) | 3.28e-05 | 141 | 115 | 5 | 0fc06c2325249aa4ae65c0ace1ec3f953372f2e4 | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.74e-05 | 145 | 115 | 5 | 9b69bfdbf91ef197b4c483617aa67498d9d2cd79 | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.74e-05 | 145 | 115 | 5 | 31af9fce1dcd7e8ae1604476598e099232017ee9 | |
| ToppCell | PND28-Epithelial-Epithelial_Airway-Neurosecretory|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.74e-05 | 145 | 115 | 5 | 76f0cde9acdc3ad5948c007dccf312665972c9e6 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.26e-05 | 149 | 115 | 5 | 58c1ac5a46898021224b9cb1483a0c58554bc4fb | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 4.26e-05 | 149 | 115 | 5 | 6e9ca280a599d96f8956ef26f2a46b9484de5488 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 4.54e-05 | 151 | 115 | 5 | 8216462e723fec2797387929dde095370947e10a | |
| Drug | 8-ethoxycaffeine | 1.63e-06 | 111 | 116 | 7 | CID000011347 | |
| Drug | geldanamicin | GAD2 HK2 CYP2E1 POLA1 PIK3R3 TOM1L1 PRPF40A THBS1 IGF1R MYOM2 CNR1 | 3.33e-06 | 373 | 116 | 11 | CID000003460 |
| Drug | dimethyl phthalate | ABCC4 HK2 ATR MYO10 PIK3R3 PEPD STK38 PSMC5 SKIL DICER1 ITPR1 TUBGCP3 GAN PIP5K1B TOP2B | 3.52e-06 | 714 | 116 | 15 | ctd:C024629 |
| Drug | Yohimbine hydrochloride [65-19-0]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 8.09e-06 | 198 | 116 | 8 | 6777_UP | |
| Drug | V0509 | 1.09e-05 | 272 | 116 | 9 | CID000102191 | |
| Drug | benzoquinone | 1.20e-05 | 209 | 116 | 8 | CID000004650 | |
| Drug | imidazole | 1.51e-05 | 10 | 116 | 3 | ctd:C029899 | |
| Drug | aflatoxin B1-2,3-oxide | 1.51e-05 | 10 | 116 | 3 | ctd:C006426 | |
| Drug | AC1NSWD2 | 2.57e-05 | 2 | 116 | 2 | CID005318091 | |
| Disease | fragile X syndrome (implicated_via_orthology) | 4.20e-05 | 3 | 111 | 2 | DOID:14261 (implicated_via_orthology) | |
| Disease | malignant pleural mesothelioma (implicated_via_orthology) | 4.20e-05 | 3 | 111 | 2 | DOID:7474 (implicated_via_orthology) | |
| Disease | fetal alcohol spectrum disorder (biomarker_via_orthology) | 8.37e-05 | 4 | 111 | 2 | DOID:0050696 (biomarker_via_orthology) | |
| Disease | Schizophrenia | DOCK4 GAD2 ABCA1 CYP2E1 SDCCAG8 GRIN2B DICER1 FABP5 THBS1 TENM4 SLC26A7 CNR1 | 1.25e-04 | 883 | 111 | 12 | C0036341 |
| Disease | platelet component distribution width | RAPSN MYH13 SYNE1 SDCCAG8 LRRK2 STK38 IGF1R AIF1 PIP5K1B PREX1 TCF7L1 | 1.33e-04 | 755 | 111 | 11 | EFO_0007984 |
| Disease | Parkinson Disease | 3.04e-04 | 85 | 111 | 4 | C0030567 | |
| Disease | Endometrioma | 3.66e-04 | 161 | 111 | 5 | C0269102 | |
| Disease | Endometriosis | 3.66e-04 | 161 | 111 | 5 | C0014175 | |
| Disease | type 1 diabetes mellitus (implicated_via_orthology) | 4.29e-04 | 39 | 111 | 3 | DOID:9744 (implicated_via_orthology) | |
| Disease | Alzheimer's disease (is_marker_for) | 4.35e-04 | 257 | 111 | 6 | DOID:10652 (is_marker_for) | |
| Disease | high grade glioma (is_implicated_in) | 5.34e-04 | 42 | 111 | 3 | DOID:3070 (is_implicated_in) | |
| Disease | obsolete_red blood cell distribution width | RAPSN ATR FXR2 DIPK1A C19orf47 PEPD CCNF IGF1R CDCA7 RNASEH2C ATP11A RP1 PPP1R36 CDH1 | 5.36e-04 | 1347 | 111 | 14 | EFO_0005192 |
| Disease | Adenoid Cystic Carcinoma | 5.63e-04 | 100 | 111 | 4 | C0010606 | |
| Disease | Pancreatic Neoplasm | 5.63e-04 | 100 | 111 | 4 | C0030297 | |
| Disease | Malignant neoplasm of pancreas | 6.07e-04 | 102 | 111 | 4 | C0346647 | |
| Disease | Thyroid carcinoma | 6.13e-04 | 44 | 111 | 3 | C0549473 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 6.23e-04 | 181 | 111 | 5 | DOID:684 (is_implicated_in) | |
| Disease | Colorectal Neoplasms | 6.44e-04 | 277 | 111 | 6 | C0009404 | |
| Disease | Malignant neoplasm of salivary gland | 6.55e-04 | 45 | 111 | 3 | C0220636 | |
| Disease | Salivary Gland Neoplasms | 7.45e-04 | 47 | 111 | 3 | C0036095 | |
| Disease | Prostatic Intraepithelial Neoplasias | 7.54e-04 | 11 | 111 | 2 | C0282612 | |
| Disease | Diabetic Retinopathy | 7.54e-04 | 11 | 111 | 2 | C0011884 | |
| Disease | level of Sterol ester (27:1/20:5) in blood serum | 7.54e-04 | 11 | 111 | 2 | OBA_2045197 | |
| Disease | myopathy (implicated_via_orthology) | 7.92e-04 | 48 | 111 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | myeloid white cell count | SLC25A24 GAD2 RAPSN RASA2 DNAH10 PIK3R3 PEPD GUCY1A1 RP1 PREX1 TCF7L1 | 8.23e-04 | 937 | 111 | 11 | EFO_0007988 |
| Disease | mean reticulocyte volume | 8.83e-04 | 799 | 111 | 10 | EFO_0010701 | |
| Disease | progression free survival, urinary bladder cancer | 9.03e-04 | 12 | 111 | 2 | EFO_0004920, MONDO_0001187 | |
| Disease | Short Rib-Polydactyly Syndrome | 1.06e-03 | 13 | 111 | 2 | C0036996 | |
| Disease | male infertility (implicated_via_orthology) | 1.06e-03 | 13 | 111 | 2 | DOID:12336 (implicated_via_orthology) | |
| Disease | Peripheral Nervous System Diseases | 1.12e-03 | 54 | 111 | 3 | C4721453 | |
| Disease | Saldino-Noonan Syndrome | 1.24e-03 | 14 | 111 | 2 | C0036069 | |
| Disease | Majewski Syndrome | 1.24e-03 | 14 | 111 | 2 | C0024507 | |
| Disease | diabetic neuropathy (implicated_via_orthology) | 1.24e-03 | 14 | 111 | 2 | DOID:9743 (implicated_via_orthology) | |
| Disease | polyp of colon | 1.24e-03 | 56 | 111 | 3 | MONDO_0021400 | |
| Disease | platelet measurement | 1.25e-03 | 315 | 111 | 6 | EFO_0005036 | |
| Disease | neutrophil count, eosinophil count | 1.29e-03 | 213 | 111 | 5 | EFO_0004833, EFO_0004842 | |
| Disease | Rhabdomyosarcoma | 1.43e-03 | 15 | 111 | 2 | C0035412 | |
| Disease | Benign neoplasm of stomach | 1.84e-03 | 17 | 111 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 1.84e-03 | 17 | 111 | 2 | C0496905 | |
| Disease | extrahepatic cholestasis (biomarker_via_orthology) | 1.84e-03 | 17 | 111 | 2 | DOID:13619 (biomarker_via_orthology) | |
| Disease | Carcinoma in situ of stomach | 1.84e-03 | 17 | 111 | 2 | C0154060 | |
| Disease | methylcobalamin deficiency type cblE, overall survival, ovarian carcinoma, response to cisplatin | 1.84e-03 | 17 | 111 | 2 | EFO_0000638, EFO_0001075, GO_0072718, MONDO_0009354 | |
| Disease | colorectal cancer | 2.05e-03 | 604 | 111 | 8 | MONDO_0005575 | |
| Disease | level of Phosphatidylcholine (20:4_0:0) in blood serum | 2.06e-03 | 18 | 111 | 2 | OBA_2045110 | |
| Disease | BMI-adjusted waist-hip ratio, physical activity measurement | 2.27e-03 | 69 | 111 | 3 | EFO_0007788, EFO_0008002 | |
| Disease | familial hyperlipidemia (biomarker_via_orthology) | 2.30e-03 | 19 | 111 | 2 | DOID:1168 (biomarker_via_orthology) | |
| Disease | Prostatic Neoplasms | 2.32e-03 | 616 | 111 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.32e-03 | 616 | 111 | 8 | C0376358 | |
| Disease | obesity (biomarker_via_orthology) | 2.34e-03 | 147 | 111 | 4 | DOID:9970 (biomarker_via_orthology) | |
| Disease | Malignant neoplasm of breast | SYNE1 MAGOHB SUV39H2 THBS1 SLC8A3 SERPINE2 FXR1 IGF1R CDH1 NIPBL TCF7L1 | 2.43e-03 | 1074 | 111 | 11 | C0006142 |
| Disease | Endometrial Carcinoma | 2.56e-03 | 72 | 111 | 3 | C0476089 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.64e-03 | 152 | 111 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | PR interval | 2.72e-03 | 495 | 111 | 7 | EFO_0004462 | |
| Disease | S-6-hydroxywarfarin measurement | 2.73e-03 | 368 | 111 | 6 | EFO_0803326 | |
| Disease | triglyceride measurement, body fat percentage | 2.81e-03 | 21 | 111 | 2 | EFO_0004530, EFO_0007800 | |
| Disease | Stomach Carcinoma | 2.81e-03 | 21 | 111 | 2 | C0699791 | |
| Disease | level of Phosphatidylcholine (18:1_20:4) in blood serum | 2.81e-03 | 21 | 111 | 2 | OBA_2045104 | |
| Disease | prostate cancer (is_marker_for) | 2.90e-03 | 156 | 111 | 4 | DOID:10283 (is_marker_for) | |
| Disease | blood pressure | 3.08e-03 | 22 | 111 | 2 | EFO_0004325 | |
| Disease | Lewy Body Disease | 3.08e-03 | 22 | 111 | 2 | C0752347 | |
| Disease | platelet crit | 3.19e-03 | 952 | 111 | 10 | EFO_0007985 | |
| Disease | schizophrenia (is_implicated_in) | 3.21e-03 | 78 | 111 | 3 | DOID:5419 (is_implicated_in) | |
| Disease | cancer (implicated_via_orthology) | 3.49e-03 | 268 | 111 | 5 | DOID:162 (implicated_via_orthology) | |
| Disease | nephrotic syndrome (implicated_via_orthology) | 3.67e-03 | 24 | 111 | 2 | DOID:1184 (implicated_via_orthology) | |
| Disease | lymphocyte percentage of leukocytes | 3.69e-03 | 665 | 111 | 8 | EFO_0007993 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SYVGEVVRAMDKKKV | 71 | P62195 | |
| KYEKAEIKEMGEMHR | 296 | P16422 | |
| MVMKYVRGEKESLDL | 311 | Q7Z3E2 | |
| RRVTAEMEGKYVINM | 201 | Q8N9M1 | |
| YEKEARLKETMRIMG | 661 | O95477 | |
| LKEKVVLMYDEIFMT | 21 | Q5T2E6 | |
| MYRGNTTMDIKDLVK | 46 | O75952 | |
| VAGMMVRELQKYIKH | 321 | Q9UPY3 | |
| AEMTDQYMAVKGIKR | 471 | Q14692 | |
| IERFVKIPEMGKYMD | 266 | Q9ULI1 | |
| IVLKEETRMLGLMYA | 6 | Q8NCQ3 | |
| HREVMKAVKVGMKEY | 206 | P12955 | |
| MGRYKEMLKFAVVQI | 56 | Q13702 | |
| LDEMMKIVGGHYLKV | 406 | Q15283 | |
| RMVVMHGYKAVKEAL | 76 | P05181 | |
| MKERALIDMYTEGIV | 86 | Q7RTV2 | |
| RSGTYVLIDMVLNKM | 951 | Q92932 | |
| KLYEMEILAADRGMK | 216 | Q14517 | |
| LSKVAPVIKARMMEY | 526 | Q05329 | |
| LARVRMMKGDFYVIE | 91 | P51116 | |
| MMTKDRGYGEKLISI | 1691 | Q14643 | |
| LAKVRMMKGEFYVIE | 81 | P51114 | |
| YMGELVRLILVKMAK | 301 | P52789 | |
| IKERALIDMYTEGMA | 86 | Q16772 | |
| LVIMELMTRGDLKSY | 1076 | P08069 | |
| LFEDYLMRKGKQEMV | 21 | Q9HCR9 | |
| MGIIDILQSYRLMKK | 346 | O14986 | |
| LREIMKTAVMKELYS | 231 | P21128 | |
| QMELMEYKAGKRVIG | 396 | O75037 | |
| EDLMKLIIKYGMTVV | 2071 | Q6KC79 | |
| VVDVAKLMKAYISMI | 2026 | Q9HD67 | |
| RMVGKNVKLYDMVLQ | 206 | Q8WX92 | |
| RMVIRYQMKSAVEEG | 841 | Q5S007 | |
| GDKIMALKMELAYLR | 56 | Q96LR2 | |
| GRTKKQLAMVMRYGV | 71 | P07093 | |
| KRMEYILTDIRKGHM | 671 | Q96CW5 | |
| GYMKETKRAVIFMIN | 46 | Q9BXC1 | |
| VTYKGREILMHTKEM | 976 | P09884 | |
| EYMKELGVGIALRKM | 21 | Q01469 | |
| VMFYGRKIMRKVTTL | 56 | Q6ZV29 | |
| GYINKEEMMDIVKAI | 151 | Q9NZI2 | |
| IECMVAAEIMQRYKK | 81 | P50876 | |
| TRYKKAEQMFGEMEV | 481 | O75400 | |
| MNEVITGIRIIKMYA | 276 | O15439 | |
| DIIKRYMDGMTVGVV | 646 | P23142 | |
| IMMNYDKLKSRLGEI | 256 | Q92569 | |
| DVRVMKKRAHILYEM | 1796 | P46100 | |
| EKGVYMTGKELRQCM | 2396 | Q13535 | |
| TGNTQVEYMIRIMKK | 531 | A0AVF1 | |
| KKVLEKYGDMRVTMG | 1031 | Q8N1I0 | |
| KYEDLVRMMGEIVSA | 386 | P41002 | |
| YKIELEGISVMVMRE | 71 | Q9H2C0 | |
| KTIMLKRTFEMAYVD | 331 | Q5T764 | |
| MKSRYEQVDLVGKMT | 341 | Q9BQ39 | |
| SIEMKFLTGYEVKVM | 541 | Q8NI60 | |
| AIMVYDVFGKMNKLI | 361 | P21554 | |
| KEVMEQSAGIMYRKS | 56 | Q8N2G4 | |
| GGKIMDKLRYIFSMI | 141 | Q9Y4J8 | |
| TKVMKQMDIGVYFGL | 551 | Q6PJP8 | |
| YDLKMVDMRKIVPET | 306 | Q5T7M9 | |
| KVQKEMSGLRMIYEL | 1256 | Q8IVF4 | |
| GEKVMLDIVAMFRQY | 6 | Q5SY68 | |
| MIEKSYDIMAKRITF | 2981 | Q6ZTR5 | |
| EKGVQMDRAVMLYHK | 1076 | Q96RY7 | |
| LKEMGFDRYKMVVQV | 81 | Q8WW35 | |
| MALEVGDYKINLKLM | 656 | P12830 | |
| SKNIMEEKRMNGIIY | 1511 | P56715 | |
| VMIRKEAYVHKSVME | 46 | Q96A72 | |
| DAQAAMRLYVMVKKE | 386 | Q9GZR2 | |
| LMRTQDVKYIEMKRV | 96 | Q9Y3A2 | |
| EGKLVAKRRAYMMDD | 751 | Q93008 | |
| TGHVYAMKILRKADM | 111 | Q15208 | |
| KLYKTGREMQERIMD | 241 | O75674 | |
| AESLKTLRYGKIMIM | 546 | Q02880 | |
| DKGKIMEEVMRTYLK | 526 | P12757 | |
| MDRMKKEYTDCVVTL | 706 | Q8NF91 | |
| EITKEREYMGSKMLI | 396 | Q86SQ7 | |
| SLKLGMERDAYVMIA | 396 | Q8TCU6 | |
| MERDAYVMIAEKGEK | 401 | Q8TCU6 | |
| MVLVDKHGMDKERYV | 416 | P78539 | |
| EEVMEAMGIKETRKY | 196 | Q96A35 | |
| YEMVSRVMKALVNRK | 311 | Q08945 | |
| LGKRSAILKMILMYE | 111 | P55008 | |
| AILKMILMYEEKARE | 116 | P55008 | |
| MLVRKRKTVDGYMNE | 206 | Q9BWT1 | |
| KIFGVAIYTGMETKM | 261 | P98196 | |
| EIGDVRMAKYKLMNQ | 1401 | A4UGR9 | |
| MAIVSDRKMIYEQKI | 221 | Q9Y5K5 | |
| LSVRMGKKVREYTML | 861 | Q15111 | |
| IRVVMYEGKKIMADS | 1121 | P07996 | |
| EQVGMIKEKYEHRML | 246 | Q5TCY1 | |
| KEMERIKGYQLLAML | 1446 | Q8IZQ1 | |
| VYEKLTMLDRVVMAG | 386 | Q6ZVD8 | |
| YMKEMRAKVVAECTL | 356 | Q9HCS4 | |
| LQMELMEYKTGKRII | 396 | Q7Z4S6 | |
| LMALKRMGIVSDYEK | 56 | Q9GZZ9 | |
| IKRMSFVMEYVGEVI | 271 | Q9H5I1 | |
| KSMESVMVKYDATVR | 866 | P24928 | |
| GYVMVTEEKKVSMGK | 81 | Q8TDP1 | |
| MYVKGMIQTRENDKV | 46 | Q9UKX3 | |
| MGKVKDIVINEAIYM | 116 | Q14442 | |
| MRIYKKGDIVDIKGM | 31 | P46778 | |
| MTVQYDNMGRVVKKE | 2166 | Q6N022 | |
| YMVGLVEKKEMELVL | 176 | Q96LQ0 | |
| IMYKIIEMSAIKTGV | 1021 | Q13395 | |
| MEAIELYREETAKMK | 761 | Q9UNX4 | |
| MHDLRKMYSEIDIKV | 641 | Q15029 | |
| YGVVKLMKIMGQLSD | 231 | Q96T83 | |
| GVSMLVEVYMDCKGR | 586 | Q8TE54 | |
| LIDFVKMMVKYGTIS | 306 | Q8WXD2 | |
| IYPMEVMKTRLAVGK | 306 | Q6NUK1 | |
| ILKEKAVPMIEGYMF | 771 | Q9H3U1 | |
| IKMIQGKEDDIYLMV | 576 | B1ANS9 | |
| SRVMDLKGQMIYIVE | 361 | Q02108 | |
| LTVVRKGGDMSKTMY | 416 | P57103 | |
| KKMFRRGYIAMLAVD | 276 | Q147X3 | |
| AGKVYDDMILAMSRV | 1216 | P54296 | |
| TKMIEGILYEMRVFA | 701 | Q14324 | |
| GMIGEVVMKRAYMAV | 496 | Q13224 |